• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2021 Fiscal Year Final Research Report

Functional analysis of PI4K complex for elucidation of pathogenesis and drug development of E. histolytica

Research Project

  • PDF
Project/Area Number 20K22758
Research Category

Grant-in-Aid for Research Activity Start-up

Allocation TypeMulti-year Fund
Review Section 0803:Pathology, infection/immunology, and related fields
Research InstitutionThe University of Tokyo

Principal Investigator

Watanabe Natsuki  東京大学, 大学院医学系研究科(医学部), 特任研究員 (00883323)

Project Period (FY) 2020-09-11 – 2022-03-31
KeywordsPI4K / TTC7 / phosphatidylinositol / phagocytosis / 貪食 / 赤痢アメーバ
Outline of Final Research Achievements

To understand the function of phosphatidyl inositol 4-kinase (PI4K) in Entamoeba histolytica, gene silencing (GS) strains of PI4K co-factors, TTC7 and EHI_151680 which were detected in proteome analysis of PI4K immunoprecipitated samples, were established. Phagocytosis efficiency was decreased in TTC7 and EHI_151680 gene silencing strain, suggesting PI4K and these co-factors are involved in phagocytosis. This fact is consistent with previous report about PI4P. Furthermore, HA tagged TTC7 and EHI_151680 overexpressing strains were established, and immunofluorescence assay was done to confirm the localization of co-factors. Expression level was too low, however the localization was confirmed in cytosol. This localization is same as GFP-tagged TTC7 and EHI_151680 suggesting this result support previous result and the localization is clearly cytosol.

Free Research Field

分子寄生虫学

Academic Significance and Societal Importance of the Research Achievements

PI4P/PI4KIIIα は、C型肝炎ウィルス (HCV) や、ポリオウィルスの細胞内での複製時に、重要な役割を担っていることが示されている。さらに、PI4KIIIβ は抗マラリア薬の標的としても注目され、特異的阻害剤が薬剤として開発されている。本研究により、赤痢アメーバにおいてPI4Kが貪食という重要な病原機構に関与することが明らかとなった。これは、貪食機構の解明や薬剤開発のために重要な進展となった。また、多種生物において報告がなかった、PI4Kが貪食に関与するという事実が明らかとなった。これは多種生物におけるPI4K機能解析の際にも、重要な事実となる。

URL: 

Published: 2023-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi